
å CDCã®èªéçç ç©¶è ãè©æ¬ºãšè³éæŽæµå®¹çã§ç±³åœãžéé
å èšäºã¯ãã¡ããã/Click here to read the original article.
ããŒã«ã»ããŒã»ã³ã¯ã1990幎代åŸåããCDCã§åãããã³ããŒã¯åºèº«ã®äººç©ã§ã2011幎ã«ãèªéçããã³å ¬è¡è¡çç ç©¶ã®ããã«å²ãåœãŠãããŠãã100äžãã«è¶ ã®CDC婿éãäžæ£ã«æµçšããçãã§èµ·èšŽãããŸãããããŒã»ã³ã¯ããã®è³éãç§çã«äœ¿çšããããã«è»¢çšãããšãããŸãã圌ã¯ãŸããã¯ã¯ãã³ãšèªéçã®é¢é£æ§ã¯ãªããšããç ç©¶ã®èè ãšããŠãç¥ãããŠããŸããæ¹è©å®¶ãã¡ã¯ã仿¥ã§ãåºãåŒçšãããŠãããããã®ç ç©¶ã«ã¯æ¬ é¥ããã£ããšäž»åŒµããŠããŸãã
äºé²æ¥çš®ãšèªéçã®éã«é¢é£ã¯ãªããšããç ç©¶ã§éèŠãªåœ¹å²ãæããããç±³çŸç 察çã»ã³ã¿ãŒïŒCDCïŒã®å ç§åŠè ãã2011幎ã®èµ·èšŽã«ç«¯ãçºããé»ä¿¡è©æ¬ºããã³ãããŒãã³ããªã³ã°ã®å®¹çã§ãå é±ç±³åœãžèº«æåŒãæž¡ããããã
ãã³ããŒã¯åºèº«ã§65æ³ã®ããŒã«ã»ããŒã»ã³ã¯ã1990幎代åŸåã«CDCã§ã®å€åãéå§ããã2011幎ãé£éŠå€§éªå¯©ã¯ãèªéçããã³å ¬è¡è¡çç ç©¶ã«å åœãããŠããCDCã®å©æé100äžãã«è¶ ãäžæ£æµçšããçãã§ãããŒã»ã³ã起蚎ãããããŒã»ã³ã¯è³éãç§çã«æµçšãããšãããŠããã
ãã®èµ·èšŽãšãç±³åœãšãã³ããŒã¯ã®éã«åŒãæž¡ãæ¡çŽãååšããã«ãããããããããŒã»ã³ã¯ãã³ããŒã¯ã§ç掻ãšä»äºãç¶ããŠããããããæšå¹Žã圌ã¯ã€ã³ã¿ãŒããŒã«ã®æé ã«ãããã€ãã§é®æãããã
5æ8æ¥ãç±³èªç©ºä¿å®å®ã圌ããã€ãããã¢ãã©ã³ã¿ãžè·éããããã§èšŽè¿œæç¶ããè¡ãããã
2012幎ã«ããŒã»ã³ããæéèŠæåæé ããªã¹ãã«æ²èŒããç±³ä¿å¥çŠç¥çïŒHHSïŒã¯ã圌ã®èº«æåŒãæž¡ãã®æ åãå ¬éããã
ç±³åžæ³çïŒDOJïŒã«ãããšãããŒã»ã³ã¯é»ä¿¡è©æ¬º2ä»¶ããããŒãã³ããªã³ã°9ä»¶ã§èµ·èšŽãããŠããã圌ã¯å ¬å€ãŸã§ä¿éãªãã§åŸçãããŠããã
2011幎ãããŒã»ã³ãå ±èè ãšãªã£ãç ç©¶ã¯ãã¯ã¯ãã³è¢«å®³ãåããèªéçã®åã©ããã¡ã®èŠªãæèµ·ãã蚎èšãéããããã«çšããããããããã®èšŽèšã¯ãã¯ã¯ãã³å·å®³è£åããã°ã©ã ïŒVICPïŒåã§ä¿å±ããŠãããªã ããã¹èªéçæç¶ã®äžéšã§ãã£ãã
2016幎ã®èæžãMaster Manipulator: The Explosive True Story of Fraud, Embezzlement, and Government Betrayal at the CDCïŒãã¹ã¿ãŒã»ãããã¥ã¬ãŒã¿ãŒïŒCDCã«ãããè©æ¬ºã暪é ãæ¿åºã®èä¿¡ã®ççºçãªå®è©±ïŒãã¯ããŒã»ã³äºä»¶ã«çŠç¹ãåœãŠã圌ããCDCãšããã°ãã¡ãŒããæ±ããŠãããã®ãããªãã¡ãã¡ããµãŒã«ãèªéç屿©ã«ããããããªã圹å²ãããå 責ããå ±åæžãäžããããã«å¥åº·ããŒã¿ãæäœãããäžççŽã®æªå ããšæåããŠããã
ãã«ãã¬ã³ãºã»ãã«ã¹ã»ãã£ãã§ã³ã¹ïŒCHDïŒã®ã¡ã¢ãªãŒã»ãã©ã³ãCEOã¯ãããŒã»ã³ã¯ããã¯ã¯ãã³ã¯èªéçãåŒãèµ·ãããªãããšããCDCãšè£œè¬æ¥çã®åã®äžå¿ã«ããããšè¿°ã¹ãã
CHDã®äž»ä»»ç§åŠè²¬ä»»è ã§å士å·ãæã€ãã©ã€ã¢ã³ã»ããã«ãŒã¯ãããŒã»ã³ã®ç ç©¶ããèªéçç ç©¶ã20幎以äžåŸéãããããšè¿°ã¹ãã
ãéå»ã®æ¿æš©ã¯ããŒã»ã³ã®è¿œåã«é¢å¿ã瀺ããŠããªãã£ãããã ããšMAHA Reportã¯å ±ããããã®çµæãããŒã»ã³ã¯ããã³ããŒã¯ã§ææãããããšãç¹ã«æžå¿µããæ§åããªããå ã ãšç掻ããŠãããã
HHSãšDOJã¯The Defenderããã®ã³ã¡ã³ãèŠè«ã«å¿ããªãã£ãã
ãœãŒã»ã³ãã¯ã¯ãã³ãšèªéçã®é¢é£ãåŠå®ããããã«ä»ã䜿ããããæ¬ é¥ãè«æã®å ±èè
CDCã«å®¢å¡ç ç©¶è ãšããŠæåã«åå ããåœåããœãŒã»ã³ã®ç ç©¶ã¯å 倩ç°åžžãšçºéé害ã«çŠç¹ãåœãŠãŠããŸãããããã2000幎代åé ã«ã¯ãèªéçç ç©¶ãžãšçŠç¹ãç§»ããŸããã
åžæ³çïŒDOJïŒã«ãããšã2000幎ãã2009幎ã«ãããŠãã¯ã¯ãã³ãšèªéçã®é¢é£ã«é¢ããç ç©¶ãå«ãäžé£ã®ç ç©¶ã®ããã«ããã³ããŒã¯æ¿åºã®2ã€ã®æ©é¢ã1100äžãã«ä»¥äžãåãåããŸããã
ãœãŒã»ã³ã¯2002幎ã«ãã³ããŒã¯ãžæ»ãããCDCããäžããããç ç©¶è³éã®ç®¡ç責任è ã«ãªããŸãããããããDOJãšç±³ä¿å¥çŠç¥çïŒHHSïŒã¯ããœãŒã»ã³ããã®è³éã®äžéšã暪é ãããã®äžéšã§ã¢ãã©ã³ã¿ã®äœå® ãè»2å°ããªãŒããã€ãè³Œå ¥ãããšäž»åŒµããŠããŸãã
çãããŠããäžæ£è¡çºã«ããããããããœãŒã»ã³ã¯èªéçç ç©¶ããããŠèªéçã¯ã¯ã¯ãã³ãšé¢é£ããªããšããåŸç¶ã®èšèª¬ã«åŒ·ãçè·¡ãæ®ããŸããã
äžçæ°Žéãããžã§ã¯ãïŒWorld Mercury ProjectãçŸCHDã®å身ïŒã2017幎ã«çºè¡šããå ±åã«ãããšãããœãŒã»ã³ã®ç±³åœã®ã¯ã¯ãã³é¢é£ãããžã§ã¯ããæ¿çãžã®åœ±é¿ã¯åºç¯ãã§ãã
ã圌ãäž»å°ããç ç©¶ã¯ãå»åŠç ç©¶æïŒInstitute of MedicineãçŸåšã®å šç±³å»åŠã¢ã«ãããŒïŒã®å¯©æ»ãšçµè«ã«åŒ·ã圱é¿ãäžããŸããâŠâŠåç ç©¶æãã¯ã¯ãã³äžã®ãã¡ããµãŒã«ãæ€èšããéã«ããšå ±åæžã¯è¿°ã¹ãŠããŸãã
ããããç ç©¶ã®äžã€ã§ãããããã»ã³ç ç©¶ïŒMadsen studyïŒãã¯ã2002幎ã«ãã¥ãŒã€ã³ã°ã©ã³ãå»åŠèªïŒThe New England Journal of MedicineïŒã«æ²èŒããããœãŒã»ã³ãå ±èè ãšãªããŸããã麻ç¹ã»ãããµã颚éªã»é¢šç¹ïŒMMRïŒã¯ã¯ãã³ãšèªéçã«ã€ããŠã®éå£ããŒã¹ã®ç ç©¶ã§ããããMMRã¯ã¯ãã³ãèªéçãåŒãèµ·ããããšãã仮説ã«å¯ŸããŠã匷ãå蚌ãããããšçµè«ã¥ããŸããã
ããã2017幎ã®å ±åã«ããã°ãããã»ã³ç ç©¶ã¯ãåœåããæ¬ é¥ããã£ãããšããããã®çç±ã¯ç ç©¶è ããã³ããŒãå ã®èªéçå 316人ã®ãã¡ãèšåºèšé²ãã¬ãã¥ãŒããã®ã40人ã ãã ã£ãããã§ããæšå¹Žã®æ»èªä»ãè§£æã¯ãåç ç©¶ã®çµè«ã«ããã«ç念ãæããããŸããã
2003幎ã«ã¯ãããã»ã³ãšãœãŒã»ã³ã¯å°å ç§åŠïŒPediatricsãç±³åœå°å ç§åŠäŒã®å ¬åŒèªïŒã«æ²èŒãããç ç©¶ã®å ±èè ã«ãåãé£ããŸããããã®ç ç©¶ã¯ããã¡ããµãŒã«å«æã¯ã¯ãã³ãšèªéççºççã®çžé¢ãæ¯æããªãããšããŸããã
ããã«ãŒæ°ã¯ãäž¡ç ç©¶ã®èè ããããŒã¿ãé èœããçžé¢ãèŠã€ããããªãããã«åçŽãªç®è¡ãã¹ãç¯ããæ å ±ãæ£æçã«éžå¥ããŠãCDCã®ç©èªãã圢äœã£ããšéé£ããŸããã
äž¡ç ç©¶ã¯ãã³ããŒã¯ã®äººå£ããŒã¿ã«äŸæ ããŠããŸããã2017幎ã®å ±åã«ãããšããããã®ç ç©¶ã¯ãã®çš®ã®ç ç©¶ã«å¿ èŠãªå«ç審æ»ãåé¿ããŠããŸããã
ããœãŒã»ã³ã®ããã»ã³MMR-èªéçç ç©¶ã¯ãå«çå§å¡äŒïŒIRB治éšå¯©æ»å§å¡äŒïŒœã«çžåœãããã³ããŒã¯ã®æ©é¢ïŒã«ãã審æ»ãšæ¿èªãªãã«å®æœã»å ¬è¡šãããŸããããŸããç±³åœé£éŠæ³ã§æ±ãããã幎éã®è¢«éšè ä¿è·å¯©æ»ãããœãŒã»ã³ãååŸããŠããªãã£ãããšã瀺ãããŠããŸããã
CDCããœãŒã»ã³ã«å¿ èŠãªå«çæ¿èªããªãã£ãããšãçºèŠããéããååºã¯ãã®äžåãå ±åãããç ç©¶ã¯æ€åãããŸããã§ããã代ããã«ãCDCè·å¡ã¯é èœã«é¢äžãããšã2017幎ã®å ±åã¯è¿°ã¹ãŠããŸãã
ãœãŒã»ã³ããã³ããŒã¯ã®ããŒã¿ãçšããŠç±³åœã®ã¯ã¯ãã³äºå®è¡šã«ã€ããŠçµè«ãå°ã
ãã³ããŒã¯ã®å»çããŒã¿ãçšããŠãç±³åœã®å°å ã¯ã¯ãã³æ¥çš®ã¹ã±ãžã¥ãŒã«ããç±³åœã®åã©ãã«ãããèªéçæµè¡ãšã®æœåšçé¢é£ã«ã€ããŠçµè«ãå°ãããšã«ã¯çåããããšãç±³ä¿å¥é·å®ãããŒãã»Fã»ã±ããã£ã»ãžã¥ãã¢æ°ã¯è¿°ã¹ãŠããŸãã
ã±ããã£æ°ãæšå¹ŽTrialSite Newsã«å¯çš¿ããè«èª¬ã§ãCDCã®å°å çšã¯ã¯ãã³æ¥çš®ã¹ã±ãžã¥ãŒã«ã¯ããã³ããŒã¯ãããã¯ããã«æ»ããå 容ãã§ãããçŽæ¥æ¯èŒã«ã¯ç矩ããããšææããŸããã
ã±ããã£æ°ã¯ãã¯ã¯ãã³ãšèªéçã®é¢é£ãåŠå®ãç¶ããŠããããæ°ãããã³ããŒã¯ã®ç ç©¶ãåŒçšããŸããããã®äžéšã¯ããœãŒã»ã³ãçããCDCã®è³éãå€é¡ã«æµçšããå倧西æŽç¥çµç«åŠã¢ã©ã€ã¢ã³ã¹ïŒNANEAïŒãšãããã³ããŒã¯ã®ç ç©¶æ©é¢ã®ç ç©¶è ã«ãã£ãŠäœæããããã®ã§ãã
ãNANEAã®ç ç©¶ç®çã¯ãç±³åœã§ã¯ãªããã³ããŒã¯ã®å¥åº·ããŒã¿ãçšããŠãç±³åœã«ãããèªéçå¢å ã®èåŸã«ã¯ã¯ãã³ããããã©ãããæ€èšŒããç ç©¶ãè¡ãããšã§ããããšMAHAã¬ããŒãã¯è¿°ã¹ãŠããŸãã
ããœãŒã»ã³ã®ç ç©¶ãå ¬è¡šãããªããã°ã¯ã¯ãã³æ¥çã¯åŽ©å£ããŠããã ããã
2017幎ã®å ±åã«ãããšãããã»ã³âãœãŒã»ã³ã®è«æã¯ããªã ããã¹èªéç蚎èšïŒOmnibus Autism ProceedingsïŒã®äžç°ãšããŠæåºããã5000件以äžã®è«æ±ãéããæ ¹æ ãšããŠäœ¿ãããŸããã
ããããã®è«æ±ã¯ãåååŽã«æå©ã«è§£æ±ºããŠããã°ãç·é¡100åãã«ã«éãããšèŠç©ããããæ¯æãã«ã€ãªãã£ãŠããã§ãããããš2017幎ã®å ±åã¯è¿°ã¹ãŠããŸãã
ç ç©¶è ãžã§ãŒã ãºã»ã°ã«ã³ããŽã£ã°æ°ã¯ãMaster Manipulatorãã®èè ã§ãããã¯ã¯ãã³ã«ãã£ãŠå·å®³ãåããèªéçã®åã©ãã®èŠªã§ããããŸããVICPã«åŽäžãããè«æ±ã®äžã€ãæåºããã°ã«ã³ããŽã£ã°æ°ã¯ããã®åŽäžããœãŒã»ã³ãšCDCã®èª¿æ»ããããŠèæžã®å·çã®åæ©ã«ãªã£ããšè¿°ã¹ãŸããã
ã°ã«ã³ããŽã£ã°æ°ã®èª¿æ»ã¯ãã¯ã¯ãã³ãèªéçãåŒãèµ·ãããªããšããç©èªã«åèŽããçµæãåºããŠããããããœãŒã»ã³ãCDCã«ãšã£ãŠæçšã ã£ãããšãæããã«ããŸããã
ãåœæCDCå éšã§ã¯ãèªéçæµè¡ã®åå ãäœã§ããããææ¡ããŠããŠãä»åŸ5幎éã§2500äžã3000äžãã«ãåœæãšããŠã¯å€§éã䜿ã£ãŠãããããäžæ£ãé ããèªéçãšã¯ã¯ãã³ã®éã®ã·ã°ãã«ãèŠãé ãå¿ èŠããã£ãããšåæ°ã¯äž»åŒµããŸããã
åæ°ã¯ããããœãŒã»ã³ã®ç ç©¶ãå ¬è¡šãããŠããªããã°ãåœæãã¯ã¯ãã³ç£æ¥å šäœã厩å£ããŠããã ããããšè¿°ã¹ãŸããã
1995幎ãã2009幎ãŸã§ç±³äžé¢è°å¡ïŒå ±åå ïŒãåããããã«ãã»ãã©ã³ã倧統é ã2024幎æ«ã«CDCé·å®ã«æåãããã®ã®åŸã«æ€åãããã€ãã»ãŠã§ã«ãã³å»åž«ã¯ããœãŒã»ã³ã®ãçãããç ç©¶ãã圌ã®ãæå€§ã®çœªããšåŒã³ãŸããã
ãŠã§ã«ãã³æ°ã¯ããè¿°ã¹ãŸããã
ãåœŒã®æå€§ã®çœªã¯ã圌ãçãã éã§ã¯ãªããCDCãæããã«ã¯ã¯ãã³ã§é害ãè² ã£ãåã©ããã¡ã®å®¶æãæèµ·ããæ³å»·éäºãéããããã«äœ¿ã£ãã圌ã®çãããç ç©¶ã§ãã
ãããã¯ãã¯ã¯ãã³è£åããã°ã©ã ãåµèšãããéã®è°äŒã®æå³ãå®å šã«æªãããã®ã§ãããæ£çŸ©ã¯ãšãã«é ããŠããŸããç§ãã¡ã¯å®å šãªèª¬æè²¬ä»»ãšå®å šãªéææ§ãå¿ èŠãšããŠããŸããã
æ°å幎ã®çŠé®åã«çŽé¢ãããªããããŒã»ã³ã¯èªéçç ç©¶ã«ã€ããŠçœç¶ããã®ãïŒ
2011幎ã®èµ·èšŽåŸãããŒã»ã³ã¯ãã³ããŒã¯ã§ç掻ã»å°±åŽãããªã¬ãã«ãç é¢ãåãã³ããŒã¯å€§åŠã«å€åããŠãããšã2017幎ã®å ±åæžã¯è¿°ã¹ãŠããã
ã°ã«ã³ããŽã£ã°ã¯ããã³ããŒã¯ãããåºç¯ãªç ç©¶äžæ£ãé èœããåãçµã¿ã®äžç°ãšããŠãããŒã»ã³ã®èº«æåŒãæž¡ããåé¿ããå¯èœæ§ãé«ããšè¿°ã¹ãã
ããããã³ããŒã¯ãšãã®å»çã³ãã¥ããã£ããèªéçã®æµè¡ãå®è³ªçã«èš±ããŠããŸã£ããã®ãšãã§ããªãäžæ£ãšèåœã«çµ¡ãåãããŠããã®ã ãšãããã圌ãã«ãšã£ãŠæ¥µããŠå°è±¡ãæªããªããŸããã ããããã³ããŒã¯ãããŒã»ã³ãåŒãæž¡ãã¯ãããããŸããã§ããããšã°ã«ã³ããŽã£ã°ã¯èªã£ãã
ããŒã»ã³ã®èº«æåŒãæž¡ãã«ã¯æ¿æ²»çåŽé¢ãããããã³ããŒã¯çŽããªãã£ã±ã³ã«ãããšãããŒã»ã³ã¯ããã©ã³ãæ¿æš©ãç±³åœã®åžæ³å¶åºŠã«å¯ŸããŠæ¥å¢ãã«åŒ·ããŠããæ¿æ²»çå§åã®ãã³ããŒã¯äººã®ç ç²è ãšãªãå±éºãããããããŒã»ã³ã®åŒè·å£«ã¯ãã€ãåœå±ã«å¯Ÿããç±³åœã§ã¯å ¬æ£ãªè£å€ãåããããªãã ãããšäŒãããšããã
ãã³ããŒã¯æ³åçãå åçããã³ããŒã¯èŠå¯ãã¯ã·ã³ãã³D.C.ã®ãã³ããŒã¯å€§äœ¿é€šããªã¬ãã«ãç é¢ãåãã³ããŒã¯å€§åŠã¯ãã¶ã»ãã£ãã§ã³ããŒããã®ã³ã¡ã³ãèŠè«ã«å¿ããªãã£ãããã³ããŒã¯å€åçãšéŠçžåºã¯ãã¶ã»ãã£ãã§ã³ããŒãæ³åçã«æ¡å ããã
2017幎ã®å ±åæžã¯ãããŒã»ã³ãé¢äžãããšãããè©æ¬ºãæŽããã®ã¯CDCã§ã¯ãªãã圌ã®å éçšäž»ã§ãããã³ããŒã¯ã®ãªãŒãã¹å€§åŠã§ãã£ããšææããã
åå ±åæžã¯ãŸããç±³åœã®å ¬è·è ããããããªã圢ã§ãããŒã»ã³ãšè·é¢ã眮ãããšã«å€±æããããšãèšãããCDCã®è·å¡ãã£ã¢ãã»ã·ã§ã³ãã«ã¯ãããŒã»ã³ãšäžé©åãªææé¢ä¿ãç¶æãããã®åŸãªãŒãã¹å€§åŠã§èªéçç ç©¶ãäž»å°ããè·ã«å°±ããã圌女ã¯çŸåšãå倧åŠã«åšè·ããŠããã
ããã«ãŒã¯ããç±³åœãšãã³ããŒã¯ã®åæ¹ããããŒã»ã³ãåŒãæž¡ãããšã§å€±ããã®ã倧ããã£ããšè¿°ã¹ãããHHSïŒç±³ä¿å¥çŠç¥çïŒã¯é·å¹Žã«ãããããã°ãã¡ãŒãã«åã蟌ãŸããŠããŸãããã±ããã£é·å®ã®æå°ã®äžã§ã®ã¿ããã®å·šå€§ãªèª²é¡ã«åãçµãããšãã§ããã®ã§ãããšããã«ãŒã¯èªã£ãã
ã°ã«ã³ããŽã£ã°ã¯ãããŸãæ°å幎ã®åç£ã«çŽé¢ããããŒã»ã³ããåã®è»œæžãšåŒãæãã«äžæ£ãªç ç©¶ã«é¢ããæ å ±ã®é瀺ãå³ãå¯èœæ§ããããšè¿°ã¹ãã圌ã¯ããã®æ å ±ãç±³åœã®å ¬è¡è¡çåœå±è ãç ç©¶è ãå·»ã蟌ããããããªããšèªã£ãã
ããã20幎ã25幎ã«çŽé¢ãããªãã圌ã¯ã¢ã¡ãªã«ã®ååæã§æ»ã¬ããšã«ãªããŸãããšã°ã«ã³ããŽã£ã°ã¯èšã£ããã圌ã¯ãããæãã§ããããïŒããããéããã ãããè«ççã«èããã°ã圌ã¯ã«ããªã¢ã®ããã«æãããã¹ãŠã話ãã¯ãã§ããã
ãã©ã³ãã¯ããè¿°ã¹ãããç±³åœã§ç¡æéã®åç£ã«çŽé¢ããŠããä»ã圌ãèªåã®ããããšãå ±è¬è ã誰ã ã£ãã®ãããããŠåœŒãã®ç¯çœªçãªèšç»ã®å šå®¹ã«ã€ããŠçå®ãèªã£ãŠãããããšãæã¿ãŸããã